IBRX Stock Slips Overnight: Insider Sale Tests Retail Optimism Ahead Of FDA Growth Catalyst
Shares of ImmunityBio, Inc. (IBRX) slipped 0.1% overnight late Sunday as a proposed insider sale worth $1.2 million cooled retail sentiment, even as bulls continued to focus on Anktiva’s global rollout and potential label expansion.IBRX stock jumped 8% last week, marking its fourth consecutive week…